Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for Preeclampsia

25 Apr 2017

Abstract excerpt

IMPORTANCE: Preeclampsia affects approximately 4% of pregnancies in the United States. It is the second leading cause of maternal mortality worldwide and may lead to serious maternal complications, including stroke, eclampsia, and organ failure. Adverse perinatal outcomes for the fetus and newborn include intrauterine growth restriction, low birth weight, and stillbirth. Many of the complications associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Global Maternal and Child Health
Share to Maternal and fetal healthcare
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28444286
DOI: 10.1001/jama.2017.3439

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for PreeclampsiaPMID 28444286Read ↗

Recent Advances in the Prevention and Screening of PreeclampsiaSemantic proximity Read ↗

Clinical tools and biomarkers to predict preeclampsiaSemantic proximity Read ↗

Understanding Health Disparities in Preeclampsia: A Literature Review.Semantic proximity Read ↗

Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and BiomarkersSemantic proximity Read ↗

First Trimester Preeclampsia Screening and Prevention: Perspective in Chinese MainlandSemantic proximity Read ↗

Review of Laboratory Testing and Biomarker Screening for PreeclampsiaSemantic proximity Read ↗

Subtypes of Preeclampsia: Recognition and Determining Clinical UsefulnessSemantic proximity Read ↗

Preeclampsia and the Kidney: Pathophysiology and Clinical ImplicationsSemantic proximity Read ↗

Unraveling preeclampsia: Is the fibrinogen‐to‐albumin ratio the key to early risk assessment?Semantic proximity Read ↗

Acute Complications of PreeclampsiaSemantic proximity Read ↗

Diagnostic Potential of MicroRNAs as Biomarkers in the Detection of PreeclampsiaSemantic proximity Read ↗

Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of PregnancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.